Mydecine's new Scientific Advisor holds over 150 U.S. and international patents and will oversee Mydecine's mycology lab.
Cybin Corp is partnering with IntelGenx Corp to produce a new delivery system for pharmaceutical-grade psilocybin.
Hollister Biosciences announces a private placement for CAD$1.5 million, expected to close by July 12, 2020.
Psychedelic drugs represent a potentially enormous step forward in treating an epidemic for which there are currently no good treatment options.
Eleusis Therapeutics is a private psychedelics company that is turning a lot of heads with its research on micro-doses of LSD as a treatment for Alzheimer's.